Target intelligence / Profile preview

Family with sequence similarity 223 member A (non-protein coding) (FAM223A)

Target
FAM223A
Molecular classification
Long intergenic non-coding RNA (lincRNA), long non-coding RNA (lncRNA), non-protein coding RNA
01

Overview

Family with sequence similarity 223 member A (FAM223A) is a long intergenic non-coding RNA (lincRNA) gene, classified as non-protein coding and sometimes referenced as a possible pseudogene or lncRNA. It does not encode a protein and does not belong to established therapeutic target classes such as receptor, enzyme, transporter, or transcription factor. FAM223A is transcribed into a non-coding RNA over 200 nucleotides, and while the precise biological roles of this specific lincRNA are not well characterized, lincRNAs in general are known to participate in the regulation of chromatin organization, gene expression in cis or trans, stabilization of RNA molecules, and acting as molecular scaffolds or decoys. Current data do not identify FAM223A as having direct roles in recognized disease pathways, biomarker signatures, drug interactions, or targeted therapeutic mechanisms.

Other names
Protein FAM223AFAM223ACXorf52LINC00204ANCRNA00204SPCXlong intergenic non-protein coding RNA 204ANCRNA00204Afamily with sequence similarity 223 member A (non-protein coding)
02

Biological functions

Regulation of chromatin structureRegulation of gene expression (in cis and trans)RNA stabilizationChromatin remodelingFine-tuning expression of neighboring genesMolecular scaffold or decoyOther (general lincRNA functions)
03

Disease associations

Other (none specifically established for FAM223A)

Beyond the preview

Go deeper on Family with sequence similarity 223 member A (non-protein coding) (FAM223A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 223 member A (non-protein coding) (FAM223A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call